Good Life Advisors’s Avantis Emerging Markets Equity ETF AVEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.69M Buy
24,627
+32
+0.1% +$2.02K 0.11% 159
2025
Q1
$1.48M Sell
24,595
-1,111
-4% -$66.8K 0.1% 158
2024
Q4
$1.51M Buy
25,706
+239
+0.9% +$14.9K 0.11% 146
2024
Q3
$1.65M Buy
25,467
+1,316
+5% +$80.6K 0.1% 158
2024
Q2
$1.48M Sell
24,151
-762
-3% -$45.7K 0.12% 143
2024
Q1
$1.44M Sell
24,913
-597
-2% -$33.6K 0.13% 130
2023
Q4
$1.44M Buy
25,510
+277
+1% +$14.9K 0.14% 126
2023
Q3
$1.33M Buy
25,233
+505
+2% +$27.4K 0.15% 127
2023
Q2
$1.33M Buy
24,728
+6,292
+34% +$335K 0.15% 123
2023
Q1
$975K Buy
+18,436
New +$979K 0.12% 139

Other funds holding AVEM

Good Life Advisors's AVEM Position: Q2 2025 in Review

Good Life Advisors increased its Avantis Emerging Markets Equity ETF (AVEM) stake by 0.13% in Q2 2025, buying an estimated $2.02K and bringing the position to 24,627 shares worth $1.69M. The position accounts for 0.11% of the portfolio, ranked #159.

Good Life Advisors first reported a position in AVEM in Q1 2023 and has held it in 10 quarters since. 582 funds tracked by Wall St. Rank hold AVEM as of Q2 2025.

  • Good Life Advisors held 24,627 shares of Avantis Emerging Markets Equity ETF worth $1.69M as of Q2 2025.
  • Good Life Advisors bought 32 Avantis Emerging Markets Equity ETF shares in Q2 2025, an estimated $2.02K.
  • Avantis Emerging Markets Equity ETF made up 0.11% of Good Life Advisors's portfolio in Q2 2025, its #159 holding.
  • Good Life Advisors first reported a position in Avantis Emerging Markets Equity ETF in Q1 2023 and has held it in 10 quarters since.
  • 582 funds tracked by Wall St. Rank held Avantis Emerging Markets Equity ETF as of Q2 2025.

Based on Good Life Advisors's 13F filing for Q2 2025, filed 8 Aug 2025.